Cite

    Bandyopadhyay, A. et al. (2021). Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial. Lancet infectious diseases. 21 (4), pp. 559-568. [Online].